tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Randall Stanicky, 80 are a HOLD (35.24%), 138 are a BUY (60.79%), 9 are a SELL (3.96%).
Analyst Randall Stanicky works with a stock forecast success ratio of 38.93% fulfilled within 189.69 days on average. Previously, Randall Stanicky worked at RBC.
Randall Stanicky’s has documented 421 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on EGRX, Eagle Pharmaceuticals at 07-Apr-2021.
Analyst best performing recommendations are on NEOS (NEOS THERAPEUTICS).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) at 1/6/2021. The price target of $70 was fulfilled within 2 days with a profit of $7.05 (11.2%) receiving and performance score of 56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$27.11 (16.15%)
185
28 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$21.11 (12.57%)
181
2 months 18 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$27.11 (16.15%)
180
2 months 18 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-2.89 (-1.72%)
157
3 months 7 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$12.11 (7.21%)
195
3 months 21 days ago
3/5 (60%)
$21.06 (13.25%)
496
What Year was the first public recommendation made by Randall Stanicky?
